Gene therapy may offer release from sterile isolation for patients lacking immune systems Part 1

We've removed all the common verbs from this article, try and put them back correctly.

Gene therapy may offer release from sterile isolation for patients lacking immune systems Part 1 (Teacher: Michael)

A new gene therapy method the bone marrow of two young children from an "immune cell desert" into a healthy breeding ground for a variety of infection-fighting agents.

The children a form of severe combined immuno-deficiency disorder (SCID) that typically requires patients to stay in sterile environments. They now and developing normally, Italian and Israeli researchers report in the journal Science, published by the American Association for the Advancement of Science.

Specifically, the two children a form of the disease called ADA-SCID, in which they not produce the ADA enzyme necessary for immune cells. The disease controlled to a certain degree by regular injections of the bovine form of ADA, an expensive proposition in many countries.

From 30 to 50 infants with ADA-SCID born each year, but only a small portion of them diagnosed, according to study co-author Claudio Bordignon of the San Raffaele Telethon Institute for Gene Therapy and Università Vita-Salute San Raffaele in Milan.

Read the article